Files

Download

Download Full Text (1.7 MB)

Contents

  • New Approaches Revolutionize the Treatment of Advanced Melanoma: Recent breakthroughs in immunotherapy and targeted therapy have improved outcomes for patients with advanced melanoma
  • Comprehensive Tobacco Treatment Approach Helps Patients Quit on Their Terms: Kicking a tobacco habit is a formidable task. Quitting tobacco after a diagnosis of cancer, can be even more difficult
  • Targeted Drug Shows Promise Against Advanced Breast Cancer: Adding the experimental kinase inhibitor palbociclib to standard hormonal therapy may delay disease progression in patients with advanced breast cancer that is estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER@) negative
  • HOUSE CALL: Avoiding Food-Drug Interactions: Some foods and medicines don’t mix
  • INBRIEF: PKM2 Identified as Potential Prognostic Marker for Glioblastoma

Publication Date

2-1-2014

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Hwu, Patrick; Allison, James P.; Hwu, Wen-Jen; Lecagoonporn, Srisuda; Davis, Michael; Cinciripini, Paul; Rabius, Vance; Moulder, Stacy; Lu, Zhimin; Melanoma; Immunotherapy; Molecular Targeted Therapy; Tobacco Use Cessation; Counseling; Nicotine Replacement Therapy; Breast Neoplasms; Antineoplastic Agents; Food-Drug Interactions; Glioblastoma; Pyruvate Kinase.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Open

OncoLog, Volume 59, Number 02, February 2014

Share

COinS